In vivo imaging of microenvironmental and anti-PD-L1-mediated dynamics in cancer using S100A8/S100A9 as an imaging biomarker

Ganesh, 2021, Targeting metastatic cancer, Nat Med, 27, 34, 10.1038/s41591-020-01195-4 Gebhardt, 2006, S100A8 and S100A9 in inflammation and cancer, Biochem Pharmacol, 72, 1622, 10.1016/j.bcp.2006.05.017 Vogl, 2007, Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock, Nat Med, 13, 1042, 10.1038/nm1638 Kallberg, 2012, S100A9 interaction with TLR4 promotes tumor growth, PLoS One, 7, e34207, 10.1371/journal.pone.0034207 Ehrchen, 2009, The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer, J Leukoc Biol, 86, 557, 10.1189/jlb.1008647 Kwak, 2020, Distinct Populations of Immune-Suppressive Macrophages Differentiate from Monocytic Myeloid-Derived Suppressor Cells in, Cancer. Cell Rep., 33 Roth, 2003, Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules, Trends in immunology, 24, 155, 10.1016/S1471-4906(03)00062-0 Arai, 2008, S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast, Current cancer drug targets, 8, 243, 10.2174/156800908784533445 El-Rifai, 2002, Gastric cancers overexpress S100A calcium-binding proteins, Cancer Res, 62, 6823 Zhao, 2020, S100A9 as a novel diagnostic and prognostic biomarker in human gastric cancer, Scand J Gastroenterol, 55, 338, 10.1080/00365521.2020.1737883 Arai, 2001, Immunohistochemical investigation of S100A9 expression in pulmonary adenocarcinoma: S100A9 expression is associated with tumor differentiation, Oncol Rep, 8, 591 Meng, 2019, Elevated Serum S100A9 Indicated Poor Prognosis in Hepatocellular Carcinoma after Curative Resection, J Cancer, 10, 408, 10.7150/jca.28409 Zhou, 2019, The Significance of Serum S100A9 and TNC Levels as Biomarkers in Colorectal Cancer, J Cancer, 10, 5315, 10.7150/jca.31267 Cross, 2005, Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers, Histopathology, 46, 256, 10.1111/j.1365-2559.2005.02097.x Lim, 2016, Tumor-infiltrating monocytes/macrophages promote tumor invasion and migration by upregulating S100A8 and S100A9 expression in cancer cells, Oncogene, 35, 5735, 10.1038/onc.2016.107 Becker, 2015, Optical in vivo imaging of the alarmin S100A9 in tumor lesions allows for estimation of the individual malignant potential by evaluation of tumor-host cell interaction, J Nucl Med, 56, 450, 10.2967/jnumed.114.146688 Eisenblaetter, 2017, Visualization of Tumor-Immune Interaction - Target-Specific Imaging of S100A8/A9 Reveals Pre-Metastatic Niche Establishment, Theranostics, 7, 2392, 10.7150/thno.17138 Burke, 2014, Exosomes from myeloid-derived suppressor cells carry biologically active proteins, J Proteome Res, 13, 836, 10.1021/pr400879c Gerwing, 2019, The beginning of the end for conventional RECIST - novel therapies require novel imaging approaches, Nat Rev Clin Oncol, 16, 442, 10.1038/s41571-019-0169-5 Gran, 2018, Imaging, myeloid precursor immortalization, and genome editing for defining mechanisms of leukocyte recruitment in vivo, Theranostics, 8, 2407, 10.7150/thno.23632 Humphries, 2001, Cell adhesion assays, Mol Biotechnol., 18, 57, 10.1385/MB:18:1:57 Vogl, 2014, Alarmin S100A8/S100A9 as a biomarker for molecular imaging of local inflammatory activity, Nat Commun, 5, 4593, 10.1038/ncomms5593 Marshall, 2010, Single-dose intravenous toxicity study of IRDye 800CW in Sprague-Dawley rats, Mol Imaging Biol, 12, 583, 10.1007/s11307-010-0317-x Pei, 2021, Safety and Stability of Antibody-Dye Conjugate in Optical Molecular Imaging, Mol Imaging Biol, 23, 109, 10.1007/s11307-020-01536-2 Kim, 2015, Memory programming in CD8(+) T-cell differentiation is intrinsic and is not determined by CD4 help, Nat Commun, 6, 7994, 10.1038/ncomms8994 MacDonald, 2010, An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation, Blood, 116, 3955, 10.1182/blood-2010-02-266296 Foell, 2004, Proinflammatory S100 proteins in arthritis and autoimmune disease, Arthritis Rheum, 50, 3762, 10.1002/art.20631 Veglia, 2018, Myeloid-derived suppressor cells coming of age, Nat Immunol, 19, 108, 10.1038/s41590-017-0022-x Cheng, 2008, Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein, J Exp Med, 205, 2235, 10.1084/jem.20080132 Perego, 2020, Reactivation of dormant tumor cells by modified lipids derived from stress-activated neutrophils, Sci Transl Med, 12, 10.1126/scitranslmed.abb5817 Raquil, 2008, Blockade of antimicrobial proteins S100A8 and S100A9 inhibits phagocyte migration to the alveoli in streptococcal pneumonia, J Immunol, 180, 3366, 10.4049/jimmunol.180.5.3366 Srikrishna, 2012, S100A8 and S100A9: new insights into their roles in malignancy, J Innate Immun, 4, 31, 10.1159/000330095 He, 2018, Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation, Nat Med, 24, 224, 10.1038/nm.4467 Austermann, 2018, S100 proteins in rheumatic diseases, Nat Rev Rheumatol, 14, 528, 10.1038/s41584-018-0058-9 Scalea, 2018, Myeloid-Derived Suppressor Cells and Their Potential Application in Transplantation, Transplantation, 102, 359, 10.1097/TP.0000000000002022 Robert, 2020, A decade of immune-checkpoint inhibitors in cancer therapy, Nat Commun, 11, 3801, 10.1038/s41467-020-17670-y Helfen, 2018, In Vivo Imaging of Pro- and Antitumoral Cellular Components of the Tumor Microenvironment, J Nucl Med, 59, 183, 10.2967/jnumed.117.198952 Ghavami, 2009, S100A8/A9: a Janus-faced molecule in cancer therapy and tumorgenesis, Eur J Pharmacol, 625, 73, 10.1016/j.ejphar.2009.08.044